Pharmathen
Pharmathen

Pharmathen Information

Contact top employees from Pharmathen

Summary

Pharmathen is a private company that has been in the industry for 57 years. The company currently specializes in the Pharmaceuticals, Pharmaceuticals areas. The position of the CEO is occupied by Dimitris Kadis. Its headquarters is located at Amstelveen, Noord-Holland, NL. The number of employees ranges from 500 to 1.0K. The annual revenue of Pharmathen varies between 100M and 500M. To connect with Pharmathen employee register on SignalHire.

Organization Website

pharmathen.com

Social Links

facebookfacebooklinkedIn

Phone Number

31-20-799-5085, +31 (0) 20 799 5085

Industries

Headquarters Location

44, Kifissias Avenue, Marousi, Attica, 15125 GR

Employees Size

1000-5000 employees

Specialties

Generic Drugs Development, Registration, Marketing of Products & Selling of Dossiers etc., Research & Development, Manufacturing, Pharmaceuticals

SIC Code

2834

Founded

1969

Estimated Annual Revenue

$100M - 500M

Operating Status

Acquisition Pending

Competitors

Founded
Type
Employees
Revenue
Funding
1901Public
Company
10K - 50K 16.4B $11.4B
1888Public
Company
100K - 9.9M 40.2B $6.9M
1950Privately
Held
1.0K - 5.0K 323.4M $0
2003Privately
Held
100 - 250 10M $0

Employees Turnover 4 quarter 2025

Number of employees switched from or switched to
arrow
Total number all of employee turnover
Number of employees by department
arrow
Total number all of employee turnover
Length of Employment
arrow
Employee tenure at Pharmathen shows a diverse range of experience levels:
1% have been with the company for less than 1 year18% for 1–2 years20% for 3–4 years15% for 5–7 years11% for 8–10 years35% have over 11 years of service at Pharmathen
Ex-employees positions
In Company
In New Company
Contact top employees from Pharmathen
Paul Davis
Head of Business Development - North America
View
Joe Marinaro
Head of Business Development - Asia Pacific
View
Gabriel Jabbour
Head of Active Pharmaceutical Ingredients (API) Sales
View
Arun Porwal
Head of Sales Marketing
View
Shumin Koh
Business Development Senior Manager, APAC
View
M Akhtar Qureshi
Regulatory Affairs CMC Specialist
View
Keshav Shinde
Analytical Development Expert
View
Ali Sasa
Director Of Business Development
View
Salma Atmeh
Business Development Senior Manager-MENA
View
Moayad Shiekh
Business Development Project Manager
View
Shen Sunny
Director Global Procurement
View
LOGESH THANGAVELU
Senior Quality Auditor -GMP AUDIT AND COMPLIANCE, PHARMATHEN PHARMACEUTICAL, GREECE
View
Manoj Ahirrao
Senior Research Scientist
View
Apurva Bhatt
Research Associate
View
freedom Zacharia
Medical Representative
View
Morgan Fang Ma
Program Manager
View
Aamir Hussain
Business Development Associate
View
Mustafa Alhayali
Medical Representative
View
Mohammed Muqdad Hameed
Sales And Marketing Specialist
View
Ameya Kohojkar
Director of Regulatory Affairs, US
View

FAQ

Pharmathen operates in the Pharma industries. More details can be found on the official website: pharmathen.com.
The headquarters of Pharmathen are located in Marousi, Greece.
The current CEO of Pharmathen is Dimitris Kadis
You can contact Pharmathen by phone at 31-20-799-5085, +31 (0) 20 799 5085.
Pharmathen currently employs 1000-5000 people.
You can contact Pharmathen by phone at 31-20-799-5085, +31 (0) 20 799 5085, by email at info@pharmathen.com, through social media (Facebook, Facebook, LinkedIn), or via the contact form on pharmathen.com.
Pharmathen's revenue is approximately 268.3M.
Well-known competitors of Pharmathen include Teva Pharmaceuticals, Abbott, Laboratoires Expanscience and Basic Pharma.

Data Privacy

GDPR Icon

GDPR COMPLIANT

SignalHire complies with the General Data Protection Regulation (GDPR). SignalHire follows GDPR requirements, including but not limited to rights of data subjects to access, correct, or delete their personal information and supports the right to be forgotten.

CCPA Icon

CCPA COMPLIANT

SignalHire is CCPA-compliant and provides California residents the right to know, access, opt out, and request deletion of their personal data.

BACK TO TOP